Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

Diffuse large B-cell lymphoma (DLBCL) is a clinically heterogeneous lymphoid malignancy and the most common subtype of non-Hodgkin’s lymphoma in adults, with one of the highest mortality rates in most developed areas of the world. More than half of DLBLC patients can be cured with standard R-CHOP re...

Descripción completa

Detalles Bibliográficos
Autores principales: Camicia, Rosalba, Winkler, Hans C., Hassa, Paul O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676894/
https://www.ncbi.nlm.nih.gov/pubmed/26654227
http://dx.doi.org/10.1186/s12943-015-0474-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676894/
https://www.ncbi.nlm.nih.gov/pubmed/26654227
http://dx.doi.org/10.1186/s12943-015-0474-2

Ejemplares similares